Rhoen Klinikum AG (WBO:RHK) Beneish M-Score: -2.39 (As of Jun. 28, 2026)


WBO:RHK Rhoen Klinikum AG WBO:RHK
74 GF Score
Price €12.80
GF Value €13.59
! 3 Warning Signs
View Full Analysis

What is Rhoen Klinikum AG Beneish M-Score?

Rhoen Klinikum AG WBO:RHK +0.79% 74 Beneish M-Score is -2.39 as of Jun. 28, 2026. GuruFocus rates WBO:RHK with a GF Score™ of 74/100 and a GF Value™ of €13.59. The stock has 3 warning signs investors should review. Among 630 Healthcare Providers & Services companies, Rhoen Klinikum AG ranks worse than 65.71% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.39 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Rhoen Klinikum AG's Beneish M-Score or its related term are showing as below:

WBO:RHK' s Beneish M-Score Range Over the Past 10 Years
Min: -2.99   Med: -2.39   Max: -1.07
Current: -2.39

During the past 13 years, the highest Beneish M-Score of Rhoen Klinikum AG was -1.07. The lowest was -2.99. And the median was -2.39.


Rhoen Klinikum AG Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Rhoen Klinikum AG's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rhoen Klinikum AG Beneish M-Score Chart

Rhoen Klinikum AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.66 -2.38 -2.37 -2.66 -2.39

Rhoen Klinikum AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -2.39 0.00

WBO:RHK vs HCA, THC, DVA: Beneish M-Score Comparison

For the Medical Care Facilities subindustry, Rhoen Klinikum AG's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rhoen Klinikum AG Beneish M-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Rhoen Klinikum AG's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Rhoen Klinikum AG's Beneish M-Score falls into.


WBO:RHK
74GF Score
Rhoen Klinikum AG WBO:RHK
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rhoen Klinikum AG Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Rhoen Klinikum AG for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0875+0.528 * 0.9522+0.404 * 0.9721+0.892 * 1.0684+0.115 * 0.9499
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.8996+4.679 * -0.012494-0.327 * 0.903
=-2.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was €482 Mil.
Revenue was €1,705 Mil.
Gross Profit was €193 Mil.
Total Current Assets was €890 Mil.
Total Assets was €1,819 Mil.
Property, Plant and Equipment(Net PPE) was €750 Mil.
Depreciation, Depletion and Amortization(DDA) was €65 Mil.
Selling, General, & Admin. Expense(SGA) was €67 Mil.
Total Current Liabilities was €342 Mil.
Long-Term Debt & Capital Lease Obligation was €118 Mil.
Net Income was €34 Mil.
Gross Profit was €0 Mil.
Cash Flow from Operations was €57 Mil.
Total Receivables was €415 Mil.
Revenue was €1,596 Mil.
Gross Profit was €172 Mil.
Total Current Assets was €904 Mil.
Total Assets was €1,857 Mil.
Property, Plant and Equipment(Net PPE) was €764 Mil.
Depreciation, Depletion and Amortization(DDA) was €63 Mil.
Selling, General, & Admin. Expense(SGA) was €69 Mil.
Total Current Liabilities was €405 Mil.
Long-Term Debt & Capital Lease Obligation was €115 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(482.302 / 1704.72) / (415.096 / 1595.619)
=0.282922 / 0.260147
=1.0875

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(171.822 / 1595.619) / (192.786 / 1704.72)
=0.107684 / 0.11309
=0.9522

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (890.45 + 749.5) / 1819.176) / (1 - (904.11 + 764.4) / 1856.67)
=0.09852 / 0.101343
=0.9721

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1704.72 / 1595.619
=1.0684

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(62.6 / (62.6 + 764.4)) / (64.9 / (64.9 + 749.5))
=0.075695 / 0.079691
=0.9499

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(66.7 / 1704.72) / (69.4 / 1595.619)
=0.039127 / 0.043494
=0.8996

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((118.1 + 341.828) / 1819.176) / ((115 + 404.853) / 1856.67)
=0.252822 / 0.279992
=0.903

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(34.471 - 0 - 57.2) / 1819.176
=-0.012494

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Rhoen Klinikum AG has a M-score of -2.39 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.39 mean?
Rhoen Klinikum AG (WBO:RHK) has a Beneish M-Score of -2.39 as of Jun. 28, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Rhoen Klinikum AG and its competitors. According to the industry distribution chart, Rhoen Klinikum AG ranks #414 out of 630 companies in the Healthcare Providers & Services industry, placing it in the top 65.7%.
Is Rhoen Klinikum AG's Beneish M-Score too high?
Rhoen Klinikum AG's current Beneish M-Score is -2.39. Based on the distribution chart, Rhoen Klinikum AG ranks #414 out of 630 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Rhoen Klinikum AG has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does Rhoen Klinikum AG's Beneish M-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Rhoen Klinikum AG ranks #414 out of 630 companies for Beneish M-Score. This places Rhoen Klinikum AG in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Healthcare Providers & Services company?
A good Beneish M-Score depends on the Healthcare Providers & Services industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Rhoen Klinikum AG and its competitors. Rhoen Klinikum AG's current Beneish M-Score is -2.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rhoen Klinikum AG stock overvalued right now?
Rhoen Klinikum AG (WBO:RHK) has a current Beneish M-Score of -2.39. The stock's GF Value™ is €13.59, compared to a current price of €12.80 — trading 5.8% below its estimated fair value. The current Beneish M-Score is -2.39. Rhoen Klinikum AG's overall GF Score™ is 74/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Rhoen Klinikum AG (WBO:RHK), the current Beneish M-Score is -2.39 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rhoen Klinikum AG (WBO:RHK) Overvalued in 2026?

Based on GuruFocus' analysis, Rhoen Klinikum AG stock appears to be undervalued. The current stock price of €12.80 is trading 5.8% below its estimated GF Value™ of €13.59.

Key valuation signals for WBO:RHK:

  • Beneish M-Score: -2.39
  • GF Value™: €13.59 vs. price of €12.80 (5.8% below fair value)
  • GF Score™: 74/100 with 3 warning signs

No single metric tells the full story. See the WBO:RHK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Rhoen Klinikum AG Business Description

Other Exchanges 0NQH:UKRHK:Germany
Address Salzburger Leite 1, Bad Neustadt a. d. Saale, DEU, 97616
Rhoen Klinikum AG provides medical care and healthcare services. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on inpatient, semi-inpatient and outpatient healthcare basis. The company generates the entire revenue in Germany, with the Bavaria and Hesse regions contributing the majority proportions of revenue.
74GF Score

Get the complete analysis for WBO:RHK

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€12.80
Price
€13.59
GF Value